lithospermate b has been researched along with malondialdehyde in 1 studies
| Studies (lithospermate b) | Trials (lithospermate b) | Recent Studies (post-2010) (lithospermate b) | Studies (malondialdehyde) | Trials (malondialdehyde) | Recent Studies (post-2010) (malondialdehyde) |
|---|---|---|---|---|---|
| 103 | 0 | 47 | 27,849 | 1,405 | 13,922 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, J; Guan, Y; Guo, C; Quan, W; Wang, Y; Wen, A; Xi, M; Yin, Y; Zhou, D; Zhu, Y | 1 |
1 other study(ies) available for lithospermate b and malondialdehyde
| Article | Year |
|---|---|
Antioxidant properties of magnesium lithospermate B contribute to the cardioprotection against myocardial ischemia/reperfusion injury in vivo and in vitro.
Topics: Animals; Antioxidants; Drugs, Chinese Herbal; Humans; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardial Reperfusion Injury; Protective Agents; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Superoxide Dismutase | 2013 |